Skip to content

Evaluation of the hemostatic effect of absorbable bone wax on bone wounds in orthopedic surgery

Evaluation of the hemostatic effect of absorbable bone wax on bone wounds in orthopedic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126628
Enrollment
Unknown
Registered
2026-06-12
Start date
2025-11-06
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding from bone wounds in orthopedic surgery

Interventions

Test group:Johnson's Bone Wax

Sponsors

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with bone wounds requiring hemostasis. 2. Understand the trial purpose, participate voluntarily and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Subjects with severe infection of bone wounds. 2. Subjects with severe coagulation dysfunction. 3. Subjects with known hypersensitivity to polyethylene glycol and sodium carboxymethyl cellulose. 4. This product shall not be used if intraoperative hemostasis is needed and inhibition of new bone formation is required simultaneously. 5. Subjects who are considered ineligible to participate in this clinical trial by the investigator for any other reasons.

Design outcomes

Primary

MeasureTime frame
Effective hemostasis rate within 3 minutes;

Secondary

MeasureTime frame
Bone wax usage;Rate of grade A incision healing;Bone healing rate;

Countries

China

Contacts

Public ContactXianyou Zheng

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

zhengxianyou@126.com+86 189 3017 7297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026